NAFLD and cardiovascular diseases: a clinical review.
Kasper P, Martin A, Lang S, Kütting F, Goeser T, Demir M, Steffen HM. · 2021
Read NAFLD and cardiovascular diseases: a clinical review. by Kasper P, Martin A, Lang S, Kütting F, Goeser T, Demir M, Steffen HM. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8238775.txt.
Description
Kasper and co-authors review the link between fatty liver disease and cardiovascular disease. Non-alcoholic fatty liver disease is the most common chronic liver disease in Western countries. It affects about 25% of adults.
The disease often travels with obesity, diabetes, and poor blood lipids. It counts as the liver face of metabolic syndrome. Beyond liver harm, it ties to heart and vessel disease. Risks include hypertension, coronary disease, and heart rhythm faults. The review gathers clinical evidence for each link. It urges heart checks as part of liver care. Physicians meet this pairing often in metabolic clinics.
Catalog record
| CREATOR | Kasper P, Martin A, Lang S, Kütting F, Goeser T, Demir M, Steffen HM. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |